Cancer cells can evade MCL1 inhibition by upregulating untargeted pro-survival BCL2 family members, particularly BCLXL and BCL2A1, enabling continued survival despite MCL1 blockade [99]. The gene discussed is BCL2A1; the disease is cancer.